1. CMU Intellectual Repository

Browsing by Author Suradej Hongeng

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 6 to 11 of 11 < previous 
Issue DateTitleAuthor(s)
1-Apr-2011Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapyNongnuch Sirachainan; Issarang Nuchprayoon; Pattra Thanarattanakorn; Samart Pakakasama; Apasri Lusawat; Anannit Visudibhan; Mantana Dhanachai; Noppadol Larbcharoensub; Jiraporn Amornfa; Kanchana Shotelersuk; Kamornwan Katanyuwong; Saipin Tangkaratt; Suradej Hongeng
1-Jan-2019Pediatric non-Hodgkin lymphoma: Characteristics, stratification, and treatment at a single institute in ThailandWorawut Choeyprasert; Usanarat Anurathapan; Samart Pakakasama; Nongnuch Sirachainan; Duantida Songdej; Surapong Lertthammakiat; Suradej Hongeng
1-Aug-2020Pediatric primary central nervous system tumors registry in Thailand under National Health Security Office schemesBunchoo Pongtanakul; Nongnuch Sirachainan; Pacharapan Surapolchai; Pimlak Charoenkwan; Worawut Choeyprasert; Patcharee Komwilaisak; Su on Chainansamit; Nittaya Witsanuyothin; Yujinda Lertrakul; Piya Rujkijyanont; Somjai Kanjanapongkul; Darintr Sosothikul; Kleebsabai Sanpakit; Thirachit Chotsampancharoen; Somporn Wangruangsathit; Nintita Sripaiboonkij Thokanit; Sommaphun Tabjareon; Suradej Hongeng
30-Mar-2020Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): Rationale and design of the ESMMO trialNut Koonrungsesomboon; Nuttapong Ngamphaiboon; Natavudh Townamchai; Pimpisa Teeyakasem; Chaiyut Charoentum; Pimlak Charoenkwan; Rungrote Natesirinilkul; Lalita Sathitsamitphong; Touch Ativitavas; Parunya Chaiyawat; Jeerawan Klangjorhor; Suradej Hongeng; Dumnoensun Pruksakorn
1-Sep-2022Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology GroupKunanya Suwannaying; Chalinee Monsereenusorn; Piya Rujkijyanont; Piti Techavichit; Kamon Phuakpet; Pongpak Pongphitcha; Su on Chainansamit; Thirachit Chotsampancharoen; Angkana Winaichatsak; Chanchai Traivaree; Lalita Sathitsamitphong; Somjai Kanjanapongkul; Patcharee Komvilaisak; Kleebsabai Sanpakit; Apichat Photia; Panya Seksarn; Surapon Wiangnon; Suradej Hongeng
1-Sep-2022Treatment outcomes of high-dose chemotherapy plus stem cell rescue in high-risk neuroblastoma patients in ThailandKunanya Suwannaying; Piti Techavichit; Patcharee Komvilaisak; Napat Laoaroon; Nattee Narkbunnam; Kleebsabai Sanpakit; Kanhatai Chiengthong; Thirachit Chotsampancharoen; Lalita Sathitsamitphong; Chalongpon Santong; Panya Seksarn; Suradej Hongeng; Surapon Wiangnon
Showing results 6 to 11 of 11 < previous